The performance of companies tied to blockbuster drugs like Viagra presents a nuanced investment scenario . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key territories has introduced substantial risk . Investors are now facing the impact of rival medications , reduc